| Issue | Title | |
| Vol 6, No 4 (2013) | Фармакоэкономический анализ использования лираглутида в составе комбинированной терапии в лечении сахарного диабета 2-го типа | Abstract |
| A. Yu. Kulikov, I. V. Novikov | ||
| Vol 7, No 1 (2014) | ABC END VEN ANALYSYS OF COSTS FOR MEDICINE SAND MEDICAL TREATMENT COSTS PATIENT | Abstract PDF (Rus) |
| M. A. Shapovalova, L. R. Koretskaya | ||
| Vol 8, No 4 (2015) | ABC-, VEN и частотный анализ терапии фибрилляции предсердий в условиях «типичной практики» | Abstract |
| Vol 8, No 4 (2015) | ABC-, VEN- AND FREQUENCY ANALYSIS OF TREATMENT OF ATRIAL FIBRILLATION IN OUTCOME PATIENTS | Abstract PDF (Rus) |
| A. N. Korobeynikova, S. V. Malchikova | ||
| Vol 10, No 3 (2017) | ABC – АНАЛИЗ ФАРМАКОТЕРАПИИ ОБОСТРЕНИЙ БРОНХИАЛЬНОЙ АСТМЫ У ДЕТЕЙ В УСЛОВИЯХ СТАЦИОНАРА | Abstract |
| , | ||
| Vol 10, No 3 (2017) | ABC-analysis of pharmacotherapy in children hospitalized with bronchial asthma exacerbations | Abstract PDF (Rus) |
| O. V. Zhukova, S. V. Kononova | ||
| Vol 7, No 2 (2014) | ANALYSIS OF DRUG PRODUCTS ASSORTMENT ACQUIRABLE BY HEALTHCARE ORGANIZATIONS FOR MEDICAL TREATMENT IN HOSPITAL SETTINGS WAS CONDUCTED | Abstract PDF (Rus) |
| M. G. Malaev | ||
| Vol 7, No 4 (2014) | ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY | Abstract PDF (Rus) |
| D. V. Fedyaev, V. K. Fedyaeva, V. V. Omelyanovsky | ||
| Vol 11, No 1 (2018) | Antimicrobial therapy of community-acquired pneumonia in a hospital setting (clinical and economic aspects) | Abstract PDF (Rus) |
| O. V. Zhukova, O. V. Ruina, M. V. Khazov, S. V. Romanov | ||
| Vol 7, No 4 (2014) | APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES | Abstract PDF (Rus) |
| V. V. Omelyanovskiy, V. K. Fedyaeva, O. Yu. Rebrova | ||
| Vol 12, No 3 (2019) | Approaches to assessing the demand for medical personnel in the Russian Federation | Abstract PDF (Rus) |
| S. N. Tishkina , T. G. Alkhasov , D. V. Lukyantseva , T. P. Bezdenezhnykh | ||
| Vol 8, No 4 (2015) | APPROACHES TO THE CONCEPTS OF PRODUCTIVITY, EFFICIENCY AND EFFECTIVENESS IN THE FIELD OF SCIENTIFIC RESEARCH AND DEVELOPMENT | Abstract PDF (Rus) |
| O. F. Seliverstova | ||
| Vol 8, No 2 (2015) | ASSESSMENT OF ECONOMIC EFFICIENCY OF APPLICATION OF RALTEGRAVIR BY PATIENTS WITHOUT EXPERIENCE OF TYPE 1 HIV INFECTION THERAPY IN RUSSIA | Abstract PDF (Rus) |
| Elamin H. Elbasha, Elena Aleksandrovna Pyadushkina, Maria Vladimirovna Avxentyeva, Alexander Gennadievich Tolkushin, Maxim Yurievich Frolov | ||
| Vol 7, No 3 (2014) | ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION | Abstract PDF (Rus) |
| M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
| Vol 12, No 3 (2019) | Availability and Pharmacoeconomics of Insulin Therapy in Countries with the Largest Number of Diabetics | Abstract PDF (Eng) |
| S. V. Ponomarenko | ||
| Vol 10, No 1 (2017) | BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS | Abstract PDF (Rus) |
| E. A. Pyadushkina | ||
| Vol 8, No 1 (2015) | BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD | Abstract PDF (Rus) |
| A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina | ||
| Vol 9, No 2 (2016) | BUDGET IMPACT ANALYSIS OF PERAMPANEL FOR ADJUNCTIVE TREATMENT IN EPILEPSY PATIENTS 12 YEARS OF AGE AND OLDER FOR PARTIAL ONSET SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION AND PRIMARY GENERALIZED TONIC-CLONIC SEIZURES IN THE RUSSIAN FEDERATION | Abstract PDF (Rus) |
| V. R. Mkrtchyan, A. M. Sergeev, K. I. Pochigaeva, I. A. Shpak | ||
| Vol 6, No 1 (2013) | CHIEF EDITOR`S COLUMN | Abstract |
| R. I. Yagudina | ||
| Vol 12, No 3 (2019) | Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support | Abstract PDF (Rus) |
| E. V. Eliseeva , E. S. Maneeva , R. K. Goncharova , A. V. Kropotov | ||
| Vol 7, No 1 (2014) | CLINICAL AND ECONOMIC ANALYSIS IN ASSESSMENT OF HEALTH CARE TECHNOLOGIES IN HEALTH CARE INSTITUTIONS | Abstract PDF (Rus) |
| I. B. Gaykovaya, A. T. Burbello, A. I. Ermakov, A. S. Fedorenko, T. V. Vavilova, M. V. Komok | ||
| Vol 8, No 2 (2015) | CLINICAL AND ECONOMIC ANALYSIS OF THE USE OF DIFFERENT TYPES OF SYSTEMS OF VENOUS ACCESS IN THE TREATMENT OF CHILDREN WITH CANCER | Abstract PDF (Rus) |
| Maksim Yur'evich Rykov, Vladimir Georgievich Polyakov | ||
| Vol 5, No 3 (2012) | CLINICAL AND ECONOMIC BENEFITS OF HUMAN INSULIN ANALOGUESUSE | Abstract PDF (Rus) |
| E. E. Arinina, M. A. Rashyd | ||
| Vol 11, No 2 (2018) | Clinical and economic efficiency of the loop ileostomy closure by various methods | Abstract PDF (Rus) |
| A. V. Veselov, S. I. Achkasov, O. I. Sushkov, A. I. Moskalev, I. S. Lantsov | ||
| Vol 10, No 2 (2017) | CLINICAL AND ECONOMIC EVALUATION OF CHRONIC DISEASE TREATMENT: A DISCREPANCY BETWEEN THE TRADITIONAL PHARMACOECONOMIC AND SOCIO-ECONOMIC ANALYSES | Abstract PDF (Rus) |
| O. V. Zhukova, S. V. Kononova | ||
| Vol 10, No 1 (2017) | CLINICAL AND ECONOMIC EVALUATION OF ERIBULIN EFFECTIVENESS IN SOFT TISSUE SARCOMA: RESULTS OF META-ANALYSIS | Abstract PDF (Rus) |
| P. V. Мazin, I. V. Sheshunov, N. K. Mazina, E. M. Markova | ||
| Vol 7, No 2 (2014) | CLINICAL AND ECONOMIC EVALUATION OF IVABRADINE USE IN STABLE ANGINA IN TERMS OF REPUBLIC OF BELARUS HEALTH CARE SYSTEM | Abstract PDF (Rus) |
| I. N. Kozhanova, I. S. Romanova, L. N. Gavrilenko, A. V. Patseev, M. M. Sachek | ||
| Vol 9, No 3 (2016) | CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY | Abstract PDF (Rus) |
| E. A. Pyadushkina, M. Yu. Frolov | ||
| Vol 8, No 4 (2015) | CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS | Abstract PDF (Rus) |
| E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva | ||
| Vol 11, No 4 (2018) | Clinical and economic studies on pharmacotherapy of malignant neoplasms: the modeling approach | Abstract PDF (Rus) |
| A. G. Tolkushin, S. K. Zyryanov, N. L. Pogudina, M. V. Davydovskaya | ||
| Vol 7, No 1 (2014) | CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT | Abstract PDF (Rus) |
| I. I. Shteynberg, S. K. Zyryanov, Yu. B. Belousov | ||
| Vol 8, No 2 (2015) | CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA | Abstract PDF (Rus) |
| Elena Albertovna Sobko, Natalya Vladimirovna Gordeeva, Angelina Yurievna Kraposhina, Irina Anatolyevna Soloveva, Svetlana Vladimirovna Chubarova, Olga Petrovna Ishenko, Irina Vladimirovna Demko, Maria Michailovna Loktionova | ||
| Vol 11, No 2 (2018) | Comments to the article by O. Yu. Rebrova and co-authors «Screening at the first stage of periodical health checkup: a systematic review of long-term results» | Abstract PDF (Rus) |
| V. A. Aksenov | ||
| Vol 12, No 3 (2019) | Comorbidity in elderly patients with atrial fibrillation affects the “cost of illness” | Abstract PDF (Rus) |
| S. V. Malchikova , N. S. Maksimchuk-Kolobova, M. V. Kazakovtseva | ||
| Vol 9, No 1 (2016) | COMPARATIVE CLINICAL AND ECONOMIC ANALYSIS OF THE INTENSIFICATION THERAPY IN PATIENTS WITH UNCONTROLLED DIABETES TYPE 2 USING BASAL INSULIN OR DAPAGLIFLOZIN | Abstract PDF (Rus) |
| V. I. Petrov, S. V. Nedogoda, M. Yu. Frolov, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova, V. Yu. Khripaeva | ||
| Vol 10, No 2 (2017) | COMPARATIVE COST-MINIMIZATION AND BUDGET-IMPACT ANALYSIS OF FIXED-DOSE INHALED CORTICOSTEROID / LONG-ACTING BETAAGONIST COMBINATIONS IN THE TREATMENT OF ASTHMA | Abstract PDF (Rus) |
| N. L. Pogudina, E. G. Kosolapov, F. S. Kochenkov, A. V. Karaulov, N. L. Bondarenko, D. V. Blinov | ||
| Vol 12, No 2 (2019) | Comparative modeling of socio-economic burden among smokers, nonsmokers and former smokers | Abstract PDF (Rus) |
| E. V. Radchenko, A. S. Kolbin | ||
| Vol 10, No 3 (2017) | Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients | Abstract PDF (Rus) |
| N. K. Mazina, P. V. Mazin | ||
| Vol 8, No 3 (2015) | COMPARATIVE PHARMACOECONOMIC STUDY OF VITAMIN-MINERAL COMPLEXES FOR REHABILITATION DURING THE PERIOD OF INCREASED NEEDS FOR MICRONUTRIENTS | Abstract PDF (Rus) |
| A. Yu. Belinskaya, I. Yu. Torshin, T. R. Grishina, O. A. Gromova | ||
| Vol 9, No 4 (2016) | COMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANY | Abstract PDF (Rus) |
| V. S. Dombrovskiy, G. R. Khachatryan | ||
| Vol 12, No 2 (2019) | Concerning the “repression” of ω -3 polyunsaturated fatty acids by adepts of evidence-based medicine | Abstract PDF (Rus) |
| I. Yu. Torshin, O. A. Gromova, Zh. D. Kobalava | ||
| Vol 9, No 3 (2016) | COPAYMENTS OF THE CITIZENS IN HEALTHCARE SYSTEM: INTERNATIONAL PRACTICE | Abstract PDF (Rus) |
| A. P. Tatarinov, D. V. Lukyantseva, L. S. Melnikova, V. V. Omelyanovskii | ||
| Vol 5, No 2 (2012) | COST EFFECTIVENESS OF ORAL PERICALCITOL IN PATIENTS WITH STAGE III-IV CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYREOSIS | Abstract PDF (Rus) |
| A. V. Rudakova | ||
| Vol 9, No 4 (2016) | COST MINIMIZATION SHALL NOT KILL PEOPLE FINAL RELEASE OF VII RUSSIAN CONGRESS OF PATIENTS | Abstract PDF (Rus) |
| Editorial article | ||
| Vol 5, No 1 (2012) | COST OF ILLNESS ANALYSIS: TYPES, METHODOLOGY, RUSSIAN SPECIFICS | Abstract |
| R. I. Yagudina, I. Yu. Zinchuk, M. M. Litvinenko | ||
| Vol 9, No 1 (2016) | COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA | Abstract PDF (Rus) |
| G. R. Khachatryan, D. V. Fedyaev, M. V. Avxentyeva, V. S. Dombrovskiy | ||
| Vol 6, No 2 (2013) | COST-EFFECTIVENESS ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS | Abstract |
| R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov | ||
| Vol 10, No 2 (2017) | COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD | Abstract PDF (Rus) |
| E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov | ||
| Vol 10, No 2 (2017) | COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD | Abstract PDF (Rus) |
| E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov | ||
| Vol 10, No 2 (2017) | COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS | Abstract PDF (Rus) |
| M. B. Kubaeva, Y. Sh. Gushchina | ||
| 1 - 50 of 257 Items | 1 2 3 4 5 6 > >> | |
Browse Title Index
Keywords
COPD
NAFLD
QALY
budget impact analysis
chemotherapy
children
clinical and economic analysis
cost-effectiveness analysis
cost-utility analysis
direct costs
drug supply
drugs
health technology assessment
multiple myeloma
non-alcoholic steatohepatitis
pharmacoeconomic analysis
pharmacoeconomic studies
pharmacoeconomics
pharmacoepidemiology
rare diseases
systematic review
Publisher: IRBIS LLC
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
